Bio-Rad Droplet Digital PCR World 2024
This live virtual broadcast from Guangzhou, China will feature renowned experts from the APAC region, alongside global leaders, showcasing how ddPCR is revolutionizing molecular diagnostics, oncology research, and various novel applications. Whether you're in research, clinical diagnostics, or biopharmaceutical manufacturing, this is your chance to explore how ddPCR technology can accelerate your work and enhance precision.
By attending this live virtual APAC event, you will:
- Gain exclusive insights from leading ddPCR experts with a primary focus on oncology and new applications relevant to the APAC region.
- Learn about innovative use cases and the latest ddPCR techniques tailored to your field.
- Explore real-world examples of ddPCR's impact in oncology research, clinical diagnostics, and beyond.
- Engage directly with ddPCR experts and ask them your burning questions.
Speakers :
Morning Plenary
Progress of Precision Medicine in Lung Cancer through Single-cell Genomics and Digital PCR
Dr. Xu Chao Zhang
Director of Medical Research Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences
Novel Applications of Droplet Digital PCR Prof Allen Chan Professor of Chemical Pathology, Faculty of Medicine, The Chinese University of Hong Kong
Clinical utility of circulating tumour DNA to guide treatment in early breast cancer patients Dr Isaac GarciaMurillas Staff Scientist, The Institute of Cancer Research (United Kingdom)
Empty/Full rAAV Capsid Characterization: Quantifying Viral Genome and Capsid Titers in a Single ddPCR Reaction Tyler Lindgren Associate Scientist, BridgeBio Gene Therapy (United States)
Application of droplet digital PCR in Forensic Medicine Dr Jiangwei Yan, Professor, Forensic Medical College of Shanxi Medical University
Oncology Track
From Feasibility to Clinical Testing for Rare Variants in Oncology: 10 years of ddPCR Experiences Dr Gary Pestano Chief Development Officer, Biodesix
Applications of droplet digital PCR technology in a clinical diagnostic laboratory for paediatric leukaemia – our experience in a decade Dr Lu Yi Senior Research Fellow, National University of Singapore
Validation of a multiplex hypermethylation-based blood test for detecting hepatocellular carcinoma: A prospective case control study Dr Srikar Raman Co-Founder and CEO, Tvaster Genkalp Chennai
Biomarkers detection with ddPCR for early cancer testing Dr Cheng He Vice President of Research and Development, MiRXES
Diagnostic utility of ddPCR in Solid Tumor Molecular Diagnostics: Indian Tertiary Cancer Centre Perspective Dr Omshree Shetty Asst Professor and Scientific Officer E, Molecular Pathology, Tata Memorial Hospital
The importance of the dMIQE guidelines for molecular testing in oncology Dr Eloise Busby Senior Researcher, National Measurement Laboratory, LGC
Novel Applications Track
Detection of Genome Editing Outcomes by ddPCR Dr Yuichiro Miyaoka Principal Investigator, Tokyo Metropolitan Institute of Medical Science
Assessment of gene-editing efficiency for rare diseases using ddPCR Dr YongSam Kim CEO, GenKore
Stool Microbial Biomarker Test to Aid Diagnosis of Inflammatory Bowel Disease (IBD) through ddPCR Dr Jiaying Zheng Microbiota I-Center (MAGIC) Limited
Swab to Droplet: predicting the risk for preterm births Dr Deepak Modi Head-Molecular and Cellular Biology Laboratory, ICMR-National Institute for Research in Reproductive and Child Health
ddPCR application in wastewater testing Dr Kwanrawee Joy Sirikanchana Senior Research Scientist, Chulabhorn Research Institute